Macular Edema
📧 Sign up to get email alerts when something new happens for Macular Edema.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2025-10-24EMA Authorised: Ozurdex (dexamethasone) — AbbVie Deutschland GmbH & Co. KG
The European Medicines Agency authorised Ozurdex (dexamethasone intravitreal implant) for the treatment of macular edema and uveitis. The de…
-
EMA approval · 2024-03-26EMA Authorised: Ximluci (ranibizumab) — STADA Arzneimittel AG
European Medicines Agency authorised Ximluci (ranibizumab) for indications including wet age-related macular degeneration, macular edema, an…